Jim Cramer Says Eli Lilly’s Pipeline Is 'Challenged'

TheStreet's Jim Cramer is concerned about what Eli Lilly has in its pipeline of new prospects.
Author:
Publish date:

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer is concerned about shares of Eli Lilly (LLY) - Get Report . 'Eli Lilly has become a challenged company in terms of their pipeline - there isn't much in it,' Cramer said. 'I am more concerned than ever that their Alzheimer's drug may not be as big as I thought.' Cramer's charitable trust, Action Alerts PLUS, recently sold all of its shares of Eli Lilly.

At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.